So, primary endpoint that was not meet was considering combination of Bet with both statins.

But the company was originally planed to do combination testing with creators, which they thought is a better statin (I know that as well as I was on Lipitor and changed to Crestor)! 

We might still have that shoot at goal, which will be disclosed on Nov 16.

And We night assume that’s why the webcast was basically setup to tell investirs (the little 30% holders) not to sell!!!

Very hopeful indeed!